Stock Events

Stock Events

Pathfinder Cell Therapy 

$0.000100
2
+$0.00+0%Thursday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.0001
52W Low
0.000001
Volume
500
Avg. Volume
0
Mkt Cap
66,716.1
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q4 2013
Q1 2014
Q2 2014
Q3 2014
Q4 2014
Q1 2015
Q2 2015
-0
-0
-0
0
Expected EPS
N/A
Actual EPS
-0.0004

Financials

-Profit Margin
Unprofitable
2009
2010
2011
2012
2013
2014
0Revenue
-1.39MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics focuses on gene editing technologies, directly competing in the innovative cell therapy space.
Intellia Therapeutics
NTLA
Mkt Cap1.75B
Intellia Therapeutics is a leader in CRISPR/Cas9 technology, a direct competitor in the gene editing and cell therapy field.
Editas Medicine
EDIT
Mkt Cap410.06M
Editas Medicine operates in the genome editing space, making it a direct competitor in developing novel cell therapies.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, including therapies for genetic diseases, competing in similar markets.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals, known for its work in treating cystic fibrosis, is expanding into cell and genetic therapies.
Alnylam Pharmaceuticals
ALNY
Mkt Cap22.1B
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, competes in the broader market of genetic and cell-based therapies.
uniQure N.V.
QURE
Mkt Cap1.72B
uniQure is focused on gene therapy for the treatment of patients with severe genetic diseases, sharing therapeutic targets with PFND.
Fate Therapeutics
FATE
Mkt Cap249.23M
Fate Therapeutics is involved in the development of programmed cellular immunotherapies for cancer and immune disorders, competing in cell therapy innovations.

About

Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Show More
CEO
Richard L. Franklin
Employees
1
Country
United States
ISIN
US70319A1060

Listings

OTC Link
US
PFND

0 Comments

Share your thoughts

FAQs

What is Pathfinder Cell Therapy stock price today?▼
The current price of PFND is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Pathfinder Cell Therapy stock price performance more closely on the chart.
What is Pathfinder Cell Therapy stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Pathfinder Cell Therapy stocks are traded under the ticker PFND.
Is Pathfinder Cell Therapy stock price growing?▼
PFND stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Pathfinder Cell Therapy has showed a +0% increase.
What is Pathfinder Cell Therapy market cap?▼
Today Pathfinder Cell Therapy has the market capitalization of 66,716.1
What were Pathfinder Cell Therapy earnings last quarter?▼
PFND earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pathfinder Cell Therapy revenue for the last year?▼
Pathfinder Cell Therapy revenue for the last year amounts to 0 USD.
What is Pathfinder Cell Therapy net income for the last year?▼
PFND net income for the last year is -1.39M USD.
How many employees does Pathfinder Cell Therapy have?▼
As of November 3, 2026, the company has 1 employees.
In which sector is Pathfinder Cell Therapy located?▼
Pathfinder Cell Therapy operates in the Health & Wellness sector.
When did Pathfinder Cell Therapy complete a stock split?▼
Pathfinder Cell Therapy has not had any recent stock splits.
Where is Pathfinder Cell Therapy headquartered?▼
Pathfinder Cell Therapy is headquartered in Cambridge, United States.